Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This refers to a specific systemic analgesic regimen used as the control arm in clinical trials led by Eckehart SCHÖLL for the management of acute pain in patients with clavicular fractures. The protocol consists of a multi-drug approach tailored by patient age: younger patients (<70 years) receive oral ibuprofen and metamizole, while older patients (≥70 years) receive oral acemetacin and metamizole. The regimen also includes rescue analgesia consisting of oral oxycodone hydrochloride drops and intravenous fentanyl in the emergency department setting. This combination therapy provides pain relief through the inhibition of cyclooxygenase enzymes (COX-1 and COX-2) to reduce prostaglandin synthesis and the activation of mu-opioid receptors to modulate pain perception in the central nervous system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on conventional pain management-Eckehart SCHÖLL-pain (acute).